Science

• Metabolomics study reveals dementia-linked metabolites

  Metabolomics

  A comprehensive nontargeted metabolomics analysis has revealed previously unknown classes of disease-linked metabolites in whole blood samples from dementia patients, which may have significant therapeutic implications for managing the untreatable...

• WHO setting up global framework to guide genome editing research

  Regulatory

  LONDON – The World Health Organization (WHO) is to set up a channel for confidential reporting of illegal, unregistered, unethical or unsafe human genome editing research, as part of a new governance framework it is proposing to develop.

• Host genetics study identified COVID-19 risk factors

  Clinical

  In infectious disease research, most of the research into genetic determinants of susceptibility to infection and disease severity are focused on the host. For COVID-19, for example, the delta variant’s infectivity, and how likely infection is to...

• Back to the basics for new insights, with new technology

  Conferences

  Sometimes, scientific progress comes from conceptual insights that arrive in a flash. More often, however, such progress arrives in a decidedly less glamorous, though no less important, manner.

• PolyU develops biomimetic nanosheet for cancer therapy and imaging

  Nanotechnology

  Researchers from The Hong Kong Polytechnic University said they have used two-dimensional nanosheets to develop a biomimetic nanosheet that can monitor tumor development, treat tumors and monitor the treatment progress in real-time.

• Prostate cancers illustrate equity’s prerequisites at ASCO 2021

  Conferences

  At the 2021 virtual annual meeting of the American Society for Clinical Oncology (ASCO), results of the VISION trial testing the addition of Novartis AG’s radiopharmaceutical Lutetium-177-PSMA-617 (Lutetium-PSMA) to individualized standard-of-care...